[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006]. (Q53118923)

From Wikidata

(Redirected from Q58182465)

Jump to navigation Jump to search

scientific article published in January 2017

Amorcer un traitement antipsychotique en schizophrénie : la situation au Québec de 1998 à 2006

Language	Label	Description	Also known as
English	[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].	scientific article published in January 2017	Amorcer un traitement antipsychotique en schizophrénie : la situation au Québec de 1998 à 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Amorcer un traitement antipsychotique en schizophrénie : la situation au Québec de 1998à 2006 (French)

0 references

Amorcer un traitement antipsychotique en schizophrénie : la situation au Québec de 1998 à 2006 (English)

0 references

1 reference

based on heuristic

inferred from title

object named as

Alan Cohen

3

0 references

Marie-Josée Fleury

8

object named as

Marie-Josée Fleury

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

9

object named as

Alain Lesage

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

2

object named as

Lucie Blais

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Sylvain Grignon

7

object named as

Sylvain Grignon

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

author name string

Jean-Daniel Carrier

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Josiane Courteau

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Pasquale Roberge

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Annie Larouche

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Marie-France Demers

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Marc-André Roy

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

André Delorme

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Alain Vanasse

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

language of work or name

0 references

publication date

2017

0 references

Santé Mentale au Québec

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

42

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

85-103

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

A Surveillance System to Monitor Excess Mortality of People With Mental Illness in Canada

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

New perspectives on schizophrenia in later life: implications for treatment, policy, and research

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Life expectancy and cardiovascular mortality in persons with schizophrenia

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Trajectories of the course of schizophrenia: From progressive deterioration to amelioration over three decades

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

The adequacy of pharmaceutical treatment of schizophrenia in Quebec varies with age, but is not influenced by sex or neighbourhood deprivation

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Update on typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Clinical management of negative symptoms of schizophrenia: An update

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Polypharmacy for schizophrenia.

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Practical considerations on the use of the Charlson comorbidity index with administrative data bases

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

The pathways to mental health care of first-episode psychosis patients: a systematic review

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

First episode psychosis and the trail to secondary care: help-seeking and health-system delays

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Characteristics and heterogeneity of schizoaffective disorder compared with unipolar depression and schizophrenia - a systematic literature review and meta-analysis

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Psychosis induced by amphetamines

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Harnessing big data for health

1 reference

https://api.crossref.org/works/10.7202%2F1040245AR

21 January 2018

Identifiers

10.7202/1040245AR

0 references

Erudit article ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/28792563

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53118923&oldid=1996230791"